Evidence map›Paper›PMID 34703996›Full record

ArticleiScience2021

RSV infection-elicited high MMP-12-producing macrophages exacerbate allergic airway inflammation with neutrophil infiltration.

Airi Makino, Takehiko Shibata, Mashiro Nagayasu, Ikuo Hosoya, Toshiyo Nishimura, Chihiro Nakano, Kisaburo Nagata, Toshihiro Ito, Yoshimasa Takahashi, Shigeki Nakamura

Open access · goldAbstract read
In one paragraph

Article in iScience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. The role of innate immune system in respiratory viral infection related asthma.Frontiers in cellular and infection microbiology · 2025
    Review
  7. Article
  8. Review
  9. Molecular Mechanisms of RSV and Air Pollution Interaction: A Scoping Review.International journal of molecular sciences · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Airi MakinoDepartment of Microbiology, Tokyo Medical University, Tokyo 160-8402, Japan.
Takehiko ShibataDepartment of Microbiology, Tokyo Medical University, Tokyo 160-8402, Japan.
Mashiro NagayasuDepartment of Immunology, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
Ikuo HosoyaGraduate School of Health Care Science, Bunkyo Gakuin University, Tokyo 113-8668, Japan.
Toshiyo NishimuraDepartment of Immunology, Nara Medical University, Kashihara, Nara 634-8521, Japan.
Chihiro NakanoDivision of Respiratory Medicine, Department of Internal Medicine, Toho University Ohashi Medical Center, Tokyo 153-0044, Japan.
Kisaburo NagataDepartment of Biomolecular Science, Faculty of Science, Toho University, Chiba 274-8510, Japan.
Toshihiro ItoDepartment of Immunology, Nara Medical University, Kashihara, Nara 634-8521, Japan.
Yoshimasa TakahashiDepartment of Immunology, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
Shigeki NakamuraDepartment of Microbiology, Tokyo Medical University, Tokyo 160-8402, Japan.
Toho University · JPNara Medical University · JPNational Institute of Infectious Diseases · JPBunkyo Gakuin University · JPToho University Ohashi Medical Center · JPTokyo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Respiratory syncytial virus (RSV) infection often exacerbates bronchial asthma, but there is no licensed RSV vaccine or specific treatments. Here we show that RSV-induced alveolar macrophages, which produce high levels of matrix metalloproteinase-12 (MMP-12), exacerbate allergic airway inflammation with increased neutrophil infiltration. When mice subjected to allergic airway inflammation via exposure to the house dust mite antigen (HDM) were infected with RSV (HDM/RSV), MMP-12 expression, viral load, neutrophil infiltration, and airway hyperresponsiveness (AHR) were increased compared to those in the HDM and RSV groups. These exacerbations in the HDM/RSV group were attenuated in MMP-12-deficient mice and mice treated with MMP408, a selective MMP-12 inhibitor, but not in mice treated with dexamethasone. Finally, M2-like macrophages produced MMP-12, and its production was promoted by increase of IFN-β-induced IL-4 receptor expression with RSV infection. Thus, targeting MMP-12 represents a potentially novel therapeutic strategy for the exacerbation of asthma.

Indexed as

Cell biologyImmunologyPathophysiologyVirology

Identifiers

PMID34703996
PMCPMC8524145
OpenAlexW3201704679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.